Selection context
Start with the research question, analyte, species, and the information that must be compared.
Assay-selection guide →Selected ELISA product records
Before you order
Make the selection question explicit
This workflow is a documentation and comparison aid, not a universal compatibility decision. The product record, supplier documentation, laboratory requirements, and intended research design remain the sources to verify before use.
- 01
Define the research question
Write down the measurement or comparison the study needs to support. This keeps the search connected to a specific research purpose rather than to a familiar product name.
- 02
Name the analyte
Record the target as it appears in the catalogue and note any terminology used in the study plan. Similar-sounding targets should not be treated as interchangeable without documentation.
- 03
Confirm the species
Use the human or animal route as an organizing aid, then check the individual record. Species category is a selection criterion, not evidence that every matrix or study design is supported.
- 04
Check source-supported specimen information
Look for specimen, sample, or matrix information in the available product documentation. Do not infer suitability from the target name or from a related product.
- 05
Review protocol and documentation
Compare the supplied protocol, required materials, controls, calibration information, and other documented conditions with the planned workflow. Use the assay-selection guide to structure this review.
Verification boundary: Catalogue organization helps locate records; it does not establish clinical validity, universal compatibility, performance, or interchangeability. Verify the product record and current supplier documentation against the intended research design before use.
Coverage model
Species routes and analyte-family routes answer different first questions
A product may be discoverable through more than one catalogue route, but a category label should not be read as proof of equivalence between products. Use the matrix to choose a starting point, then review the canonical product record for the target, species designation, documentation, and other details relevant to the planned research.
Route
Human examples
Animal examples
Analyte-family examples
What to verify next
SpeciesWho or what is represented?
Human ELISA kits
Hemopexin and IgE records
Hemopexin and IgE records
Animal ELISA kits
Cat CRP and Rat Osteopontin records
Cat CRP and Rat Osteopontin records
Species is separate from analyte-family classification.
Species designation and product documentation
Analyte familyWhat is being organized?
Human Hemopexin and Human IgE are supplied record identities.
Cat CRP and Rat Osteopontin are supplied record identities.
Biomarker research
HEL is described in its supplied record as a biomarker for early-stage oxidation research.
HEL is described in its supplied record as a biomarker for early-stage oxidation research.
Target identity, specimen information, and protocol
Focused routeHow narrow is the route?
Immunoglobulins
Human IgE pathway
Human IgE pathway
Animal route
Cat and rat records supplied
Cat and rat records supplied
Immunoglobulins
Use the route as catalogue navigation, not as a claim of product interchangeability.
Use the route as catalogue navigation, not as a claim of product interchangeability.
Final availability and record-level scope
Allocation note: The examples above reflect supplied catalogue records. Availability depends on the final category allocation and the current product record. Related labels should not be used to infer interchangeable products or assay performance.
Use the resources alongside the catalogue
Turn a product search into a documented review
Educational resources are decision support. They help organize questions about an assay workflow; they do not replace the product record, supplier documentation, or the research team’s own verification.
Controls and plate structure
Use a deliberate plate plan to make control placement and comparison logic visible before the run.
Read about ELISA controls →Calibration and data review
Keep standard-curve review connected to the data and avoid extending an interpretation beyond what was examined.
Review standard curves →Precision and matrix questions
Separate within-run and between-run considerations from matrix, spike-recovery, and parallelism questions.
Explore the evidence map →Transparent records
Document the product record, protocol version, controls, batches, and decisions that shaped the workflow.
Read reporting guidance →